Literature DB >> 11984027

The young competitive athlete with cardiovascular abnormalities: causes of sudden death, detection by preparticipation screening, and standards for disqualification.

Barry J Maron1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11984027     DOI： 10.1023/a:1017903709361

Source DB:  PubMed          Journal:  Card Electrophysiol Rev        ISSN： 1385-2264


× No keyword cloud information.
  16 in total

1.  Preparticipation screening for the detection of cardiovascular abnormalities that may cause sudden death in competitive athletes.

Authors:  F Pigozzi; A Spataro; F Fagnani; N Maffulli
Journal:  Br J Sports Med       Date:  2003-02       Impact factor: 13.800

2.  Familial hypertrophic cardiomyopathy can be characterized by a specific pattern of orientation fluctuations of actin molecules .

Authors:  J Borejdo; D Szczesna-Cordary; P Muthu; N Calander
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

3.  Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain.

Authors:  Wenrui Huang; Katarzyna Kazmierczak; Zhiqun Zhou; Vanessa Aguiar-Pulido; Giri Narasimhan; Danuta Szczesna-Cordary
Journal:  Arch Biochem Biophys       Date:  2016-02-22       Impact factor: 4.013

4.  Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction.

Authors:  Priya Muthu; Li Wang; Chen-Ching Yuan; Katarzyna Kazmierczak; Wenrui Huang; Olga M Hernandez; Masataka Kawai; Thomas C Irving; Danuta Szczesna-Cordary
Journal:  FASEB J       Date:  2011-09-01       Impact factor: 5.191

5.  Cross-bridge kinetics in myofibrils containing familial hypertrophic cardiomyopathy R58Q mutation in the regulatory light chain of myosin.

Authors:  P Mettikolla; N Calander; R Luchowski; I Gryczynski; Z Gryczynski; J Zhao; D Szczesna-Cordary; J Borejdo
Journal:  J Theor Biol       Date:  2011-06-24       Impact factor: 2.691

Review 6.  Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor.

Authors:  Jeffrey R Moore; Leslie Leinwand; David M Warshaw
Journal:  Circ Res       Date:  2012-07-20       Impact factor: 17.367

7.  Kinetics of a single cross-bridge in familial hypertrophic cardiomyopathy heart muscle measured by reverse Kretschmann fluorescence.

Authors:  Prasad Mettikolla; Nils Calander; Rafal Luchowski; Ignacy Gryczynski; Zygmunt Gryczynski; Julian Borejdo
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

8.  Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy.

Authors:  Katarzyna Kazmierczak; Ellena C Paulino; Wenrui Huang; Priya Muthu; Jingsheng Liang; Chen-Ching Yuan; Ana I Rojas; Joshua M Hare; Danuta Szczesna-Cordary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-07       Impact factor: 4.733

Review 9.  Pseudophosphorylation of cardiac myosin regulatory light chain: a promising new tool for treatment of cardiomyopathy.

Authors:  Sunil Yadav; Danuta Szczesna-Cordary
Journal:  Biophys Rev       Date:  2017-01-25

10.  Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.

Authors:  Wenrui Huang; Jingsheng Liang; Katarzyna Kazmierczak; Priya Muthu; Divya Duggal; Gerrie P Farman; Lars Sorensen; Iraklis Pozios; Theodore P Abraham; Jeffrey R Moore; Julian Borejdo; Danuta Szczesna-Cordary
Journal:  J Mol Cell Cardiol       Date:  2014-06-30       Impact factor: 5.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.